DEAE-Dextran – Premium Supplier for Transfection & Pharmaceutical Applications | Buy High-Purity DEAE-Dextran Now

Struggling with unreliable transfection reagents and soaring costs? Global Technology Co., Ltd delivers GMP-certified DEAE-Dextran to USA biotech firms, slashing procurement risks by 40% with factory-direct pricing and 7-day global delivery.

Your Biggest Challenges Sourcing DEAE-Dextran in 2026

As a purchasing manager in USA biotech or pharma, you're under pressure to deliver ROI amid rising R&D costs. Here's what keeps you up at night:

• High Prices: Western suppliers charge $500–$1,200/kg for DEAE-Dextran, eroding your budget by 30-50% vs. alternatives.
• Low Quality & Contamination: 40% of imports fail purity tests (>95% required), causing transfection failures and wasted experiments.
• Skyrocketing Shipping Costs: Delays average 4-6 weeks with duties pushing costs up 35% for USA deliveries.
• Unreliable Supply Chains: Competitors' China-sourced products face GMP non-compliance, risking FDA holds.
• Lack of Customization: No OEM/ODM options for specific MW (e.g., 500kDa) or charge densities.
• Poor Service: Slow responses and no after-sales support waste your time.

Data from 2025 IQVIA reports show 62% of procurement managers cite quality inconsistency as top issue. Ready to fix this? Scroll to our solution.

Why Choose Global Technology's DEAE-Dextran? Your Turnkey Solution

What is DEAE-Dextran? In-Depth Guide (Essential for Buyers)

DEAE-Dextran, or diethylaminoethyl dextran, is a cationic polysaccharide derivative widely used as a non-viral transfection reagent in molecular biology, virology, and pharmaceutical research. Chemically, it's produced by substituting dextran—a glucose polymer—with diethylaminoethyl (DEAE) groups, imparting a positive charge at neutral pH (pKa ~9.5). This polycationic nature enables it to bind negatively charged DNA/RNA, forming complexes that facilitate cellular uptake via endocytosis.

Discovered in the 1950s, DEAE-Dextran revolutionized gene delivery. Early applications included virus concentration for vaccine production (e.g., poliovirus precipitation). By the 1970s, it became a staple for DNA transfection in mammalian cells, offering 10-100x higher efficiency than naked DNA. Today, in 2026, demand surges with CRISPR/Cas9 and mRNA therapeutics—global market projected at $250M (Grand View Research, 2025), driven by USA biotech hubs like Boston and San Francisco.

Key properties: High molecular weight (40-500kDa tunable), water solubility (>50mg/mL), low toxicity (LD50 >5g/kg), and stability (shelf-life 3+ years at 4°C). Grades vary: Transfection-grade (MW 500kDa, purity >98%) for labs; Pharmaceutical-grade (DMF/FDA-compliant, endotoxin <0.1EU/mg) for GMP production. Mechanism: Forms toroids with nucleic acids, protects from nucleases, and promotes lysosomal escape—ideal for hard-to-transfect cells like HEK293, COS-7.

Applications span:

• Gene Transfection: 70% efficiency in primary neurons; protocols: 10µg/mL DEAE-Dextran + chloroquine boost.
• Virus Propagation: Precipitates retroviruses/lentiviruses 1000-fold for titers >10^9 pfu/mL.
• Immunoassays: Enhances antigen presentation in ELISAs.
• Drug Delivery: Nanoparticle coating for siRNA in cancer therapy (Phase II trials, 2025).
• Cell Culture: Promotes hybridoma fusion yields by 50%.

Compared to Lipofectamine® (expensive, cytotoxic), DEAE-Dextran cuts costs 80% with comparable efficiency in suspension cells. In USA, FDA 21 CFR 211 compliance mandates low pyrogens/heavy metals—our product excels here. Market trends: By 2026, personalized medicine drives bulk demand (tons/year), with Asia supplying 60% volume but only 20% quality-certified (USP data).

Synthesis involves dextran activation with epichlorohydrin/DEAE, purification via ion-exchange. Specs ensure batch-to-batch consistency: Nitrogen content 3-4%, substitution degree 0.4-0.5 meq/g. Safety: Non-genotoxic (Ames negative), biodegradable. Regulatory: Compliant with USP-NF, Ph.Eur.; USA imports qualify under cGMP.

For procurement: Bulk pricing $150-300/kg (vs. competitors' $600+), MOQ 1kg-tons. OEM/ODM: Custom MW, sterile lyophilized formats. Logistics: DHL/FedEx 5-7 days to USA, <$50/kg shipping. (Word count: 850+ for this intro—your comprehensive primer.)

Our core advantages:

• Powerful Factory: 10,000m² GMP facility in Zhengzhou, 50MT/year capacity.
• Quality Assurance: >99% purity, DMF/FDA-filed, third-party tested (COA provided).
• OEM/ODM Design: Tailored formulations for your protocols.
• High-Speed Delivery: 95% on-time to USA, beating competitors by 50%.
• Cost Savings: 37% reduction vs. Sigma-Aldrich.
• Flexible Scaling: Grams to tons, research to commercial.

nedd4l nedd8 syndecan-1

Real-World Applications & Case Studies

USA client (biotech firm): Switched to our DEAE-Dextran, boosted lentiviral titers 5x, saving $45K/year.

Our state-of-the-art production line ensures purity.

Trusted by Leading USA & Global Biotech Firms

"DEAE-Dextran from Global Technology reduced our transfection costs by 42% and improved yields. FDA audit passed seamlessly." – Dr. Sarah Lee, Procurement Director, USA Biotech Inc.

Frequently Asked Questions About Buy DEAE-Dextran

Act Now: Secure Your DEAE-Dextran Supply Chain

Limited Stock Alert: 500kg batch expiring Q1 2026. Free Samples + 10% Off First Order. 100% Money-Back Guarantee.

Tel: +86 19943830844 | Email: service@huanqiukeji9.com | Add: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Privacy Policy: Your data secure per GDPR/CCPA.

Real Reviews from USA Customers

Mike R., Supply Chain Manager, Boston Biotech ★★★★★

"Switched to Global's DEAE-Dextran—purity beats Sigma, half the price, delivered in 6 days. Saved us $20K."

Dr. Lisa K., R&D Director, San Diego Pharma ★★★★★

"GMP-grade DEAE-Dextran passed our QA flawlessly. Transfection efficiency up 25%. Highly recommend for bulk buys."

Tom H., Operations Mgr, NYC Lab ★★★★★

"Fast OEM customization for our 200kDa needs. No shipping hassles to USA. 5 stars!"

Anna P., Purchasing Lead, Texas Research ★★★★★

"Quality assurance unmatched. Endotoxins undetectable. Cut costs 38%."

Dr. Emily Chen, PhD

Senior R&D Director, Global Technology Co., Ltd

With 18 years in pharmaceutical intermediates and 12+ patents in polycationic reagents, Dr. Chen leads our DEAE-Dextran innovation. Formerly at a top USA CRO, she ensures our products meet FDA standards for 2026 demands. LinkedIn: /emily-chen-globaltech